SE8205533D0 - Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan - Google Patents

Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan

Info

Publication number
SE8205533D0
SE8205533D0 SE8205533A SE8205533A SE8205533D0 SE 8205533 D0 SE8205533 D0 SE 8205533D0 SE 8205533 A SE8205533 A SE 8205533A SE 8205533 A SE8205533 A SE 8205533A SE 8205533 D0 SE8205533 D0 SE 8205533D0
Authority
SE
Sweden
Prior art keywords
aminoal
procedure
preparation
therapeutic effect
cooling range
Prior art date
Application number
SE8205533A
Other languages
English (en)
Other versions
SE8205533L (sv
SE454882B (sv
Inventor
B J Price
J W Clitherow
J Bradshaw
Original Assignee
Allen & Hanburys Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27448487&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8205533(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB32465/76A external-priority patent/GB1565966A/en
Priority claimed from KR7701808A external-priority patent/KR810000355B1/ko
Application filed by Allen & Hanburys Ltd filed Critical Allen & Hanburys Ltd
Publication of SE8205533L publication Critical patent/SE8205533L/sv
Publication of SE8205533D0 publication Critical patent/SE8205533D0/sv
Publication of SE454882B publication Critical patent/SE454882B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/64—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE8205533A 1976-08-04 1982-09-28 Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan SE454882B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB32465/76A GB1565966A (en) 1976-08-04 1976-08-04 Aminoalkyl furan derivatives
GB5068576 1976-12-06
GB2018777 1977-05-13
KR7701808A KR810000355B1 (ko) 1977-05-13 1977-08-04 아미노 알킬푸란 유도체의 제조방법

Publications (3)

Publication Number Publication Date
SE8205533L SE8205533L (sv) 1982-09-28
SE8205533D0 true SE8205533D0 (sv) 1982-09-28
SE454882B SE454882B (sv) 1988-06-06

Family

ID=27448487

Family Applications (3)

Application Number Title Priority Date Filing Date
SE7708521A SE437373B (sv) 1976-08-04 1977-07-25 Forfarande for framstellning av ett aminoalkylfuranderivat med terapeutisk verkan
SE8205533A SE454882B (sv) 1976-08-04 1982-09-28 Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE8206556A SE454883B (sv) 1976-08-04 1982-11-17 Aminoalkylfuranderivat till anvendning som mellanprodukter vid framstellning av aminoalkylfuranderivat med terapeutisk verkan

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE7708521A SE437373B (sv) 1976-08-04 1977-07-25 Forfarande for framstellning av ett aminoalkylfuranderivat med terapeutisk verkan

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8206556A SE454883B (sv) 1976-08-04 1982-11-17 Aminoalkylfuranderivat till anvendning som mellanprodukter vid framstellning av aminoalkylfuranderivat med terapeutisk verkan

Country Status (16)

Country Link
AT (1) AT375931B (sv)
CH (2) CH642072A5 (sv)
CY (1) CY1077A (sv)
DE (2) DE2759959C2 (sv)
DK (2) DK148258C (sv)
ES (2) ES461334A1 (sv)
FI (1) FI72318C (sv)
HK (1) HK55780A (sv)
IE (1) IE45456B1 (sv)
IT (2) IT1126759B (sv)
KE (1) KE3080A (sv)
NZ (2) NZ191383A (sv)
PH (1) PH13540A (sv)
PT (1) PT66874B (sv)
SE (3) SE437373B (sv)
YU (2) YU40006B (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4203909A (en) * 1978-09-26 1980-05-20 Bristol-Myers Company Furan compounds
YU52598A (sh) * 1998-11-19 2001-05-28 D.D. Zdravlje- sektor za istraživanje i razvoj POSTUPAK ZA sintezu N-[2[[[5=[(DIALKILAMINO)METIL]-2= FURANIL]METIL]TIO]ETIL]-N'-ALKIL-2-NITRO 1,1 ALKENDIAMINA I NJIHOVIH HIDROHLORIDA

Also Published As

Publication number Publication date
ES461334A1 (es) 1979-05-16
NZ184759A (en) 1980-09-12
SE454883B (sv) 1988-06-06
YU40006B (en) 1985-06-30
PH13540A (en) 1980-06-26
DK148258C (da) 1985-10-14
YU200082A (en) 1983-01-21
DK149952B (da) 1986-11-03
ES470836A1 (es) 1979-02-16
KE3080A (en) 1980-10-03
NZ191383A (en) 1980-09-12
SE7708521L (sv) 1978-02-05
AT375931B (de) 1984-09-25
DE2760097C2 (sv) 1989-08-17
PT66874B (en) 1979-01-23
DK416384A (da) 1984-08-30
IT1126759B (it) 1986-05-21
IE45456B1 (en) 1982-08-25
FI72318C (sv) 1987-05-11
CH642072A5 (en) 1984-03-30
IT8548437A0 (it) 1985-08-01
PT66874A (en) 1977-09-01
HK55780A (en) 1980-10-10
ATA574077A (de) 1984-02-15
DK337977A (da) 1978-02-05
CY1077A (en) 1980-12-27
FI772264A (sv) 1978-02-05
YU191177A (en) 1983-01-21
SE8206556D0 (sv) 1982-11-17
SE437373B (sv) 1985-02-25
SE8205533L (sv) 1982-09-28
DK148258B (da) 1985-05-20
IE45456L (en) 1978-02-04
CH641176A5 (en) 1984-02-15
SE8206556L (sv) 1982-11-17
DK149952C (da) 1987-07-06
IT1221058B (it) 1990-06-21
DE2759959C2 (sv) 1988-08-04
DK416384D0 (da) 1984-08-30
YU40088B (en) 1985-06-30
FI72318B (fi) 1987-01-30
SE454882B (sv) 1988-06-06

Similar Documents

Publication Publication Date Title
ES451467A1 (es) Procedimiento para la preparacion de nuevos esteres cuar- tenarios n-alcohilnortropinicos de acido bencilico susti- tuidos en n-beta.
ES459412A1 (es) Un metodo de preparacion de compuestos heterociclicos deri- vados de hidantoina.
SE7604476L (sv) Forfarande for framstellning av 1-(3,3,3-triarylpropyl)-4-fenyl-4-piperidinmetanolforeningar
ES460351A1 (es) Procedimiento para la preparacion de 2-bromo-6 - fluor-n-2- imidazolidinilidenbenzamina.
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
SE7703114L (sv) Guanidinderivat
SE7609495L (sv) N-tetrahydrofurfuryl-noroximorfon, dess syraadditionssalter, lekemedel innehallande dessa samt forfarande for framstellning derav
SE8205533D0 (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
ES8308547A1 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
PL246418A1 (en) Process for preparing n-/3-trifluoromethylphenyl/-n'-propargylpiperazine
GB1505849A (en) 9,10-dihydroanthracen-9,10-imine derivatives
DE3469738D1 (en) Spirobenzofuranones, their production and use
IE44951L (en) Pyridoindoles
ES455692A1 (es) Procedimiento para la produccion de derivados de alquilen- dioxipiperacina.
SE8002937L (sv) Nytt n,n'-difenylhydrazinderivat och forfarande for framstellning derav
ES459649A1 (es) Un procedimiento para la produccion de un derivado de diaza-bicicloalcano.
JPS5436252A (en) Novel propano-anthracene derivatives and their preparation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8205533-6

Effective date: 19930204

Format of ref document f/p: F